Newsletter | September 14, 2026

09.14.26 -- Smarter Recruitment, Stronger Trials: Rare Disease Strategies, Ethical Ads & DCT Solutions

SPONSOR

 

 

Clinical Leader’s Site Solutions Expo on October 7, 2026, will showcase solutions that help clinical trial sites manage growing operational demands. Attendees will learn about site activation, recruitment, patient support, payments, communication, and other services designed to reduce site burden and improve trial performance. Solution providers will demonstrate how their offerings can help sponsors, CROs, and sites execute clinical studies more effectively.

CLINICAL SITES

 

ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive Malignancies

ImvivaBio CMO Jan Davidson-Moncada, MD, Ph.D., discusses the company's Phase 1b/2 study for aggressive T-cell malignancies, explaining their unmet need, the rationale for an allogeneic approach, and plans to address immune rejection.

 

Challenges And Opportunities In Lung Cancer Clinical Development

Discover how precision medicine and novel therapeutics reshape lung cancer clinical development. Gain insights to overcome modern trial execution and global enrollment challenges.

 

How A Biopharmaceutical Company Improved Site Satisfaction

Eliminate site payment delays and reduce clinical trial admin burden. Learn how one sponsor cut payment timelines from 120+ days to under 30 days while boosting site satisfaction.

 

Collaborate To Improve The Patient Experience

Fragmented trial operations trigger costly enrollment delays. Discover how operational alignment among sponsors, CROs, and site networks drives patient retention and study success.

 

Find A Solution To Unify Clinical Supply And IRT

Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.

 

Safe-To-Site: Confidence In Clinical Trial Travel

By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.

PATIENT CENTRICITY

 

'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary Endpoint

Imbria Pharmaceuticals' Albert Kim, MD, Ph.D., shares why PROs are the point of the company's FORTITUDE-HCM trial for patients with non-obstructive hypertrophic cardiomyopathy.

 

The Triple Effect Of Community Based Clinical Trials

Clinical trial success requires more than enrollment. Learn how participant engagement and representative data can improve study outcomes and relevance.

 

Patient Payments And Travel

Eliminate financial and travel hurdles for trial participants. Unify payments and travel logistics to reduce site burden, boost participant retention, and run seamless studies.

PATIENT RECRUITMENT

 

The Patient Advocacy Strategy Behind Skyhawk's Rapid Enrollment

Skyhawk’s patient-first approach shows how advocacy partnerships, site engagement, and operational quality can accelerate enrollment without losing focus on patients.

 

Enhance Recruitment & Retention For Rare Kidney Disease Trials

Though the burdens of developing treatments for rare kidney diseases are high, data-driven recruitment strategies and experienced CRO teams will help ensure accessible trials with strong enrollment.

 

Clinical Trial Recruitment Strategies For Rare Disease Studies

By deploying mobile clinics equipped with specialized diagnostic tools and trained technicians, sponsors can execute protocol-adherent assessments right in the participant's community.

 

It's A Mad Men World For IRB Review Of Clinical Trial Advertisements

Modern digital tools and AI have transformed clinical trial recruitment, outpacing decades-old regulations. Discover how to apply core ethical principles to protect participant privacy and equity.

 

Streamline Your Study Lifecycle, Accelerate Post-Approval Research

Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.

 

DCT Solutions That Successfully Deliver Results

What impact can DCT/hybrid trial design have on overall trial success, and how does a tailored approach lead to achieving maximum results?

Connect With Clinical Leader: